Thursday, March 24, 2022 4:07:19 PM
slamminsalmon,
What this Baton device appears capable of is acting like the lymph zone in the body which is the process you are describing in your post. I read through the thread before responding because I wanted to see what other posters were concluding. One day this type of process will be utilized to create allogenic completely safe preventative cancer vaccines which the library of antigen targets that UCLA and others have will be used for. A video with Dr. Prins pointed to this years ago and flipper44 and I have referenced it several times. NWBO is WAY out front with all of this. By the way, the tumor draining lymph zone is about the most immune compromised area of the immune system from early onset of the disease. This is why Dr. Linda Liau went ex vivo for DC maturation/activation in the first place. Go NWBO! Best wishes.
What this Baton device appears capable of is acting like the lymph zone in the body which is the process you are describing in your post. I read through the thread before responding because I wanted to see what other posters were concluding. One day this type of process will be utilized to create allogenic completely safe preventative cancer vaccines which the library of antigen targets that UCLA and others have will be used for. A video with Dr. Prins pointed to this years ago and flipper44 and I have referenced it several times. NWBO is WAY out front with all of this. By the way, the tumor draining lymph zone is about the most immune compromised area of the immune system from early onset of the disease. This is why Dr. Linda Liau went ex vivo for DC maturation/activation in the first place. Go NWBO! Best wishes.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
